Subscribe   COVID-19 Resource Center twitterLinkedIn YouTube
Advancing Knowledge. Enhancing Care.
Advancing Knowledge. Enhancing Care.

Patient Care Resources

The following resources have been compiled as a resource for managing psoriasis in clinical practice. 

COVID-19 & Psoriasis

Information from around the world on coronavirus and psoriasis

Treatment Guidelines

Compilation of up-to-date guidelines for treating psoriasis
Assessments Tools for assessing and managing psoriasis
now available

COVID-19 Psoriasis Resource Center

Information from around the world on psoriasis and coronavirus to assist dermatologists and the patients they serve

explore now


Latest news

Dermavant Announces FDA Approval for VTAMA® (Tapinarof) Cream
May 26, 2022
Dermavant announced the FDA approval for VTAMA® (tapinarof) cream, 1% for the Treatment of Plaque Psoriasis in Adults. This is the first topical novel chemical entity launched for psoriasis in the U.S. in 25 years.
Bristol Myers Squibb (BMS) Announces New Two-Year Deucravacitinib Data
May 16, 2022
Bristol Myers Squibb (BMS) announced new two-year data that reinforces the durable efficacy and consistent safety profile of Deucravacitinib when used to treat moderate to severe plaque psoriasis.
Commentary: Vaccine Hesitancy and Access to Psoriasis Care in the COVID-19 Pandemic
May 11, 2022
IPC Councilor, Ulrich Mrowietz, MD, shares his expert opinion on Cook et al (Br J Dermatol 2022 (online first)) report on the interruption of psoriasis care during the COVID-19 pandemic and vaccine hesitancy in patients with psoriasis.
New Corporate Member
May 03, 2022
IPC is pleased to welcome AnaptysBio as a Bronze Level Corporate Member!
More News

Advancing Knowledge. Enhancing Care.

About Us
Strategic Plan
Annual Report
COVID-19 Resource Center
Privacy Statement
News Room
Contact Us
Subscribe 

SUPPORT OUR WORK

IPC's mission is to advance the care of people with psoriasis worldwide, through education, research and advocacy.
 IPC is not in any way engaged in the practice of medicine or acting as a physician or health care professional or provider. The information IPC publishes is not intended as a substitute for the exercise of professional medical judgement by a health care provider following examination of a patient's condition. The ultimate responsibility for a patient's diagnosis or medical treatment rests with the patient's health care provider.

International Psoriasis Council

1034 S. Brentwood Blvd., Suite 600,
St. Louis, MO USA 63117

Tel (972) 861-0503     Fax (214) 242-3391
email info@psoriasiscouncil.org

© 2020 International Psoriasis Council. All Rights Reserved.

We use cookies on this site to enhance your online experience. By continuing to use this site, you agree to accept cookies.
OK